InvestorsHub Logo
Followers 167
Posts 36086
Boards Moderated 7
Alias Born 10/20/2019

Re: ProfitScout post# 118177

Thursday, 11/02/2023 10:23:01 AM

Thursday, November 02, 2023 10:23:01 AM

Post# of 118383
Very promising News...

"Being able to substantially elevate NR2F6 levels is truly an unexpected, but welcome finding. We now have a sound scientific basis to pursue designing T cells which can tamp down on the uncontrolled immune activation seen in multiple autoimmune disorders," says Dr. Harry Lander, Chief Scientific Consultant to the Company. "We recently filed a patent application around such T cells and we feel we have a head start on this in the scientific community, particularly around using nuclear receptors such as NR2F6."

$RGBP